Genomic basis for RNA alterations revealed by whole-genome analyses of 27 cancer types

Citations Over Time

Abstract

Abstract We present the most comprehensive catalogue of cancer-associated gene alterations through characterization of tumor transcriptomes from 1,188 donors of the Pan-Cancer Analysis of Whole Genomes project. Using matched whole-genome sequencing data, we attributed RNA alterations to germline and somatic DNA alterations, revealing likely genetic mechanisms. We identified 444 associations of gene expression with somatic non-coding single-nucleotide variants. We found 1,872 splicing alterations associated with somatic mutation in intronic regions, including novel exonization events associated with Alu elements. Somatic copy number alterations were the major driver of total gene and allele-specific expression (ASE) variation. Additionally, 82% of gene fusions had structural variant support, including 75 of a novel class called “bridged” fusions, in which a third genomic location bridged two different genes. Globally, we observe transcriptomic alteration signatures that differ between cancer types and have associations with DNA mutational signatures. Given this unique dataset of RNA alterations, we also identified 1,012 genes significantly altered through both DNA and RNA mechanisms. Our study represents an extensive catalog of RNA alterations and reveals new insights into the heterogeneous molecular mechanisms of cancer gene alterations.

Related Papers

• → Excision of the Sinorhizobium meliloti Group II Intron RmInt1 as Circles in Vivo(2006)45 cited
• → Exon and protein positioning in a pre-catalytic group II intron RNP primed for splicing(2020)12 cited
• → A Mutation of cdc-25.1 Causes Defects in Germ Cells But Not in Somatic Tissues in C. elegans(2009)18 cited
• → Preferential excision of the 5' proximal intron from mRNA precursors with two introns as mediated by the cap structure.(1987)117 cited
• → Somatic PI3K activity regulates transition to the spermatocyte stages in Drosophila testis(2017)6 cited